Tasigna and Urinary incontinence - a phase IV clinical study of FDA data

Summary:

Urinary incontinence is reported as a side effect among people who take Tasigna (nilotinib hydrochloride monohydrate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Synthroid, and have Hypothyroidism.

The phase IV clinical study analyzes which people have Urinary incontinence when taking Tasigna. It is created by eHealthMe based on reports of 31,413 people who have side effects when taking Tasigna from the FDA, and is updated regularly.

What is Tasigna?

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 31,535 Tasigna users. Check the latest studies of Tasigna.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 1,635 drugs and 2,518 conditions by eHealthMe. Check the latest studies of Urinary incontinence.

On Aug, 04, 2026

31,413 people reported to have side effects when taking Tasigna.
Among them, 37 people (0.12%) have Urinary incontinence.

Could Tasigna cause Urinary incontinence?

Among these 37 people:

How long have people been on Tasigna when they have Urinary incontinence? *

What is the gender of people who have Urinary incontinence when taking Tasigna? *

female: 62.16 %
male: 37.84 %

What is the age of people who have Urinary incontinence when taking Tasigna? *

What are other drugs people take besides Tasigna? *

What are other side effects people have besides Urinary incontinence? *

Diarrhea: 11 people, 29.73%
Weakness: 11 people, 29.73%
Fatigue (feeling of tiredness): 9 people, 24.32%
Indigestion: 8 people, 21.62%
Fall: 8 people, 21.62%
Urination - Painful: 8 people, 21.62%
Abdominal Discomfort: 8 people, 21.62%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 21.62%
Gait Disturbance: 7 people, 18.92%
Weight Decreased: 7 people, 18.92%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 10.81%
High Blood Pressure: 3 people, 8.11%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.41%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 2.70%
Sleep Disorder: 1 person, 2.70%
Pain: 1 person, 2.70%
Osteoporosis (bones weak and more likely to break): 1 person, 2.70%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 2.70%
Oesophagitis (inflammation of oesophagus): 1 person, 2.70%
Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Tasigna and have Urinary incontinence?

- Check whether Urinary incontinence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tasigna:

Tasigna (31,535 reports)

Urinary incontinence treatments and more:

Urinary incontinence (50,139 reports)

How severe was Urinary incontinence and when was it recovered:

Urinary incontinence in Tasigna

Expand to all the drugs that have ingredients of nilotinib hydrochloride monohydrate:

Urinary incontinence and drugs with ingredients of nilotinib hydrochloride monohydrate (28 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tasigna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary incontinence:

Urinary incontinence (1,635 drugs)

Browse all the conditions that are associated with Urinary incontinence:

Urinary incontinence (2,518 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nilotinib hydrochloride monohydrate (the active ingredients of Tasigna) and Tasigna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.